1. Home
  2. HLX vs NRIX Comparison

HLX vs NRIX Comparison

Compare HLX & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$10.05

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$14.80

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
NRIX
Founded
1979
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
HLX
NRIX
Price
$10.05
$14.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
12
Target Price
$10.50
$30.58
AVG Volume (30 Days)
1.7M
891.7K
Earning Date
04-22-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$876,561,000.00
$76,987,000.00
Revenue This Year
$2.91
N/A
Revenue Next Year
$4.97
$26.32
P/E Ratio
$48.02
N/A
Revenue Growth
3.60
99.31
52 Week Low
$5.52
$8.18
52 Week High
$10.75
$22.50

Technical Indicators

Market Signals
Indicator
HLX
NRIX
Relative Strength Index (RSI) 65.97 42.98
Support Level $6.20 $11.34
Resistance Level $10.75 $16.47
Average True Range (ATR) 0.32 0.85
MACD 0.05 0.05
Stochastic Oscillator 92.84 36.53

Price Performance

Historical Comparison
HLX
NRIX

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: